Natriuretic Peptides and Normal Body Fluid Regulation
Author:
- 1 July 2018
- journal article
- Published by Wiley in Comprehensive Physiology
- Vol. 8 (3) , 1211-1249
Abstract
Natriuretic peptides are structurally related, functionally diverse hormones. Circulating atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are delivered predominantly by the heart. Two C‐type natriuretic peptides (CNPs) are paracrine messengers, notably in bone, brain, and vessels. Natriuretic peptides act by binding to the extracellular domains of three receptors, NPR‐A, NPR‐B, and NPR‐C of which the first two are guanylate cyclases. NPR‐C is coupled to inhibitory proteins. Atrial wall stress is the major regulator of ANP secretion; however, atrial pressure changes plasma ANP only modestly and transiently, and the relation between plasma ANP and atrial wall tension (or extracellular volume or sodium intake) is weak. Absence and overexpression of ANP‐related genes are associated with modest blood pressure changes. ANP augments vascular permeability and reduces vascular contractility, renin and aldosterone secretion, sympathetic nerve activity, and renal tubular sodium transport. Within the physiological range of plasma ANP, the responses to step‐up changes are unimpressive; in man, the systemic physiological effects include diminution of renin secretion, aldosterone secretion, and cardiac preload. For BNP, the available evidence does not show that cardiac release to the blood is related to sodium homeostasis or body fluid control. CNPs are not circulating hormones, but primarily paracrine messengers important to ossification, nervous system development, and endothelial function. Normally, natriuretic peptides are not powerful natriuretic/diuretic hormones; common conclusions are not consistently supported by hard data. ANP may provide fine‐tuning of reno‐cardiovascular relationships, but seems, together with BNP, primarily involved in the regulation of cardiac performance and remodeling. © 2017 American Physiological Society. Compr Physiol 8:1211‐1249, 2018.Keywords
This publication has 567 references indexed in Scilit:
- Silent Disease Progression in Clinically Stable Heart FailureEuropean Journal of Heart Failure, 2016
- Heterozygous Mutations in Natriuretic Peptide Receptor-B (NPR2) Gene as a Cause of Short StatureHuman Mutation, 2015
- Overgrowth syndrome associated with a gain‐of‐function mutation of the natriuretic peptide receptor 2 (NPR2) geneAmerican Journal of Medical Genetics Part A, 2013
- CNP/NPR2 signaling maintains oocyte meiotic arrest in early antral follicles and is suppressed by EGFR‐mediated signaling in preovulatory folliclesMolecular Reproduction and Development, 2012
- Contribution of comparative fish studies to general endocrinology: structure and function of some osmoregulatory hormonesJournal of Experimental Zoology Part A: Comparative Experimental Biology, 2006
- Distribution of natriuretic peptide precursor mRNAs in the rat brainJournal of Comparative Neurology, 1995
- Vascular Actions of C-Type Natriuretic Peptide in Isolated Porcine Coronary Arteries and Coronary Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1994
- Detection of C-Type Natriuretic Peptide in Human Circulation and Marked Increase of Plasma CNP Level in Septic Shock PatientsBiochemical and Biophysical Research Communications, 1994
- Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction.The EMBO Journal, 1989
- Organization of atriopeptin‐like immunoreactive neurons in the central nervous system of the ratJournal of Comparative Neurology, 1986